Tessari Eben

Insider·Kiniksa Pharmaceuticals International, plc·KNSA·Insider since 2025·Form 4 filings: 28
Trades YTD
0
Trades (12m)
18
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

18 transactions
15 Dec 2025
SOLD
$KNSA
12,048
$41.56
S
26 Nov 2025
SOLD
$KNSA
200
$42.89
S
17 Nov 2025
SOLD
$KNSA
11,825
$41.30
S
17 Nov 2025
SOLD
$KNSA
645
$40.08
S
14 Oct 2025
SOLD
$KNSA
553
$37.99
S
14 Oct 2025
SOLD
$KNSA
11,815
$37.65
S
29 Sep 2025
SOLD
$KNSA
42,000
$38.33
S
15 Sep 2025
SOLD
$KNSA
356
$37.00
S
15 Sep 2025
SOLD
$KNSA
16,044
$36.45
S
05 Sep 2025
SOLD
$KNSA
13,389
$35.66
S
04 Sep 2025
SOLD
$KNSA
85,271
$35.52
S
03 Sep 2025
SOLD
$KNSA
15,091
$35.50
S
18 Aug 2025
SOLD
$KNSA
100
$34.44
S
18 Aug 2025
SOLD
$KNSA
16,100
$33.77
S
05 Aug 2025
SOLD
$KNSA
550
$33.90
S
05 Aug 2025
SOLD
$KNSA
138,064
$33.20
S
14 Jul 2025
SOLD
$KNSA
18,900
$28.72
S
16 Jun 2025
SOLD
$KNSA
17,300
$28.28
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Kiniksa Pharmaceuticals International, plc

last 30 days

No active insider cluster at Kiniksa Pharmaceuticals International, plc in the last 30 days. Eben's recent transactions appear in the section above.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 08:30 UTC.